India-based Apollo Hospitals and AliveCor are teaming-up to tackle the growing problem of heart arrhythmias, by providing AliveCor’s mobile device to improve access to cardiac screening tools for patients across India.
Through an exclusive agreement in India and of South Asia, Apollo Hospitals will introduce the smartphone enabled, medical grade, FDA-cleared AliveCor Heart Monitor as part of its arrhythmia screening and stroke prevention program providing patients access to this device. The AliveCor Heart Monitor is compatible with iOS and Android mobile devices and can wirelessly record, display, store and transfer heart rate and single-channel electrocardiogram (ECG).
The AliveCor Heart Monitor is compatible with iOS and Android mobile devices and can wirelessly record, display, store and transfer heart rate and single-channel ECG.“It’s extremely important for us to provide access to medical devices that are both clinically proven and cost-effective to help our patients manage their cardiac health,” said Dr. Prathap C Reddy, Chairman, Apollo Hospitals. “This agreement is another step in extending the reach of our Apollo health services to members of our community, our cardiac patients and caregivers.”
Millions of people worldwide are affected by arrhythmias, which undetected can lead to stroke and even death. One in four adults over age 40 is at risk of developing atrial fibrillation, the most common heart rhythm disturbance. For the first time in India, Apollo Hospitals is making it possible for users of the AliveCor Heart Monitor to have instant access to their ECGs through their mobile devices, providing a more complete picture of their heart health.